Prosecution Insights
Last updated: April 19, 2026

Vor Biopharma Inc.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
0
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18620496 COMPOSITIONS AND METHODS FOR INHIBITION OF LINEAGE SPECIFIC PROTEINS JOHANSEN, PETER N. 1644 Non-Final OA Mar 28, 2024
18023548 COMPOSITIONS AND METHODS FOR CLL1 MODIFICATION GOMEZ RODRIGUEZ, JULIO WASHINGTON 1637 Non-Final OA Feb 27, 2023
17638607 COMPOSITIONS AND METHODS FOR CLL1 MODIFICATION SULLIVAN, DENNIS JOHN 1642 Non-Final OA Feb 25, 2022
17613387 COMPOSITIONS AND METHODS FOR CD33 MODIFICATION SU-TOBON, QIWEN NMN 1636 Non-Final OA Nov 22, 2021

Managing Vor Biopharma Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month